These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 15618970)

  • 1. Adenovirus-mediated p53 gene therapy in pediatric soft-tissue sarcoma cell lines: sensitization to cisplatin and doxorubicin.
    Ganjavi H; Gee M; Narendran A; Freedman MH; Malkin D
    Cancer Gene Ther; 2005 Apr; 12(4):397-406. PubMed ID: 15618970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus-mediated p53 gene therapy in osteosarcoma cell lines: sensitization to cisplatin and doxorubicin.
    Ganjavi H; Gee M; Narendran A; Parkinson N; Krishnamoorthy M; Freedman MH; Malkin D
    Cancer Gene Ther; 2006 Apr; 13(4):415-9. PubMed ID: 16211088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced cisplatin sensitivity of head and neck squamous cell carcinoma cell lines correlates with mutations affecting the COOH-terminal nuclear localization signal of p53.
    Mandic R; Schamberger CJ; Müller JF; Geyer M; Zhu L; Carey TE; Grénman R; Dünne AA; Werner JA
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6845-52. PubMed ID: 16203773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p73 beta-expressing recombinant adenovirus: a potential anticancer agent.
    Das S; Nama S; Antony S; Somasundaram K
    Cancer Gene Ther; 2005 Apr; 12(4):417-26. PubMed ID: 15678153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenoviral delivery of p53 gene suppresses expression of collagenase-3 (MMP-13) in squamous carcinoma cells.
    Ala-aho R; Grénman R; Seth P; Kähäri VM
    Oncogene; 2002 Feb; 21(8):1187-95. PubMed ID: 11850838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 gene transfer does not enhance E2F-1-mediated apoptosis in human colon cancer cells.
    Draus JM; Elliott MJ; Atienza C; Stilwell A; Wong SL; Dong Y; Yang H; McMasters KM
    Exp Mol Med; 2001 Dec; 33(4):209-19. PubMed ID: 11795482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin chemotherapy plus adenoviral p53 gene therapy in EBV-positive and -negative nasopharyngeal carcinoma.
    Weinrib L; Li JH; Donovan J; Huang D; Liu FF
    Cancer Gene Ther; 2001 May; 8(5):352-60. PubMed ID: 11477455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
    Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
    Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-suppressive effect of adenovirus-mediated inhibitor of growth 4 gene transfer in breast carcinoma cells in vitro and in vivo.
    Li Z; Xie Y; Sheng W; Miao J; Xiang J; Yang J
    Cancer Biother Radiopharm; 2010 Aug; 25(4):427-37. PubMed ID: 20707719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression.
    Kralj M; Husnjak K; Körbler T; Pavelić J
    Cancer Gene Ther; 2003 Jun; 10(6):457-67. PubMed ID: 12768191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additive effect of adenovirus-mediated E2F-1 gene transfer and topoisomerase II inhibitors on apoptosis in human osteosarcoma cells.
    Yang HL; Dong YB; Elliott MJ; Wong SL; McMasters KM
    Cancer Gene Ther; 2001 Apr; 8(4):241-51. PubMed ID: 11393276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
    Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
    J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wild-type p53 gene transfection in human cultured sarcomas: effect of CDDP.
    Endo K; Kuratate I; Watanabe M; Yoshida H; Teshima R; Osaki M; Ito H
    Oncol Rep; 2001; 8(3):637-42. PubMed ID: 11295094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I/II study of hepatic artery infusion with wtp53-CMV-Ad in metastatic malignant liver tumours.
    Habib NA; Hodgson HJ; Lemoine N; Pignatelli M
    Hum Gene Ther; 1999 Aug; 10(12):2019-34. PubMed ID: 10466636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitization of cis-platinum by a recombinant adenovirus vector expressing wild-type p53 gene in human ovarian carcinomas.
    Song K; Li Z; Seth P; Cowan KH; Sinha BK
    Oncol Res; 1997; 9(11-12):603-9. PubMed ID: 9563008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models.
    Wen SF; Xie L; McDonald M; DiGiacomo R; Chang A; Gurnani M; Shi B; Liu S; Indelicato SR; Hutchins B; Nielsen LL
    Cancer Gene Ther; 2000 Nov; 7(11):1469-80. PubMed ID: 11129289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-expression of ING4 and P53 enhances hypopharyngeal cancer chemosensitivity to cisplatin in vivo.
    Ren X; Liu H; Zhang M; Wang M; Ma S
    Mol Med Rep; 2016 Sep; 14(3):2431-8. PubMed ID: 27484725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
    Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
    Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modified p53 enhances apoptosis in sarcoma cell lines mediated by doxorubicin.
    Tang HJ; Qian D; Sondak VK; Stachura S; Lin J
    Br J Cancer; 2004 Mar; 90(6):1285-92. PubMed ID: 15026814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents.
    Fan S; el-Deiry WS; Bae I; Freeman J; Jondle D; Bhatia K; Fornace AJ; Magrath I; Kohn KW; O'Connor PM
    Cancer Res; 1994 Nov; 54(22):5824-30. PubMed ID: 7954409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.